Kerry Wentworth - Net Worth and Insider Trading
Kerry Wentworth Net Worth
The estimated net worth of Kerry Wentworth is at least $1 Million dollars as of 2024-11-05. Kerry Wentworth is the Chief Regulatory Officer of Flexion Therapeutics Inc and owns about 146,362 shares of Flexion Therapeutics Inc (FLXN) stock worth over $1 Million. Kerry Wentworth is also the VP, Reg Affairs & Clinical Ops of Agenus Inc and owns about 21 shares of Agenus Inc (AGEN) stock worth over $87. Details can be seen in Kerry Wentworth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kerry Wentworth has not made any transactions after 2021-07-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kerry Wentworth
Kerry Wentworth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kerry Wentworth owns 3 companies in total, including Flexion Therapeutics Inc (FLXN) , Agenus Inc (AGEN) , and Nuvation Bio Inc (NUVB) .
Click here to see the complete history of Kerry Wentworth’s form 4 insider trades.
Insider Ownership Summary of Kerry Wentworth
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FLXN | Flexion Therapeutics Inc | 2021-07-19 | Chief Regulatory Officer |
| AGEN | Agenus Inc | 2013-06-14 | VP & Clinicial & Reg & & Quality |
| NUVB | Nuvation Bio Inc | 2020-05-23 | Chief Regulatory Officer |
Kerry Wentworth Latest Holdings Summary
Kerry Wentworth currently owns a total of 2 stocks. Among these stocks, Kerry Wentworth owns 146,362 shares of Flexion Therapeutics Inc (FLXN) as of July 19, 2021, with a value of $1 Million and a weighting of 99.99%. Kerry Wentworth also owns 21 shares of Agenus Inc (AGEN) as of July 20, 2006, with a value of $87 and a weighting of 0.01%.
Latest Holdings of Kerry Wentworth
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FLXN | Flexion Therapeutics Inc | 2021-07-19 | 146,362 | 9.12 | 1,334,821 |
| AGEN | Agenus Inc | 2006-07-20 | 21 | 4.14 | 87 |
Holding Weightings of Kerry Wentworth
Kerry Wentworth Form 4 Trading Tracker
According to the SEC Form 4 filings, Kerry Wentworth has made a total of 2 transactions in Flexion Therapeutics Inc (FLXN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Flexion Therapeutics Inc is the sale of 3,944 shares on July 19, 2021, which brought Kerry Wentworth around $25,439.
According to the SEC Form 4 filings, Kerry Wentworth has made a total of 0 transactions in Agenus Inc (AGEN) over the past 5 years. The most-recent trade in Agenus Inc is the sale of 0 shares on July 20, 2006, which brought Kerry Wentworth around $0.
Insider Trading History of Kerry Wentworth
- 1
Kerry Wentworth Trading Performance
Kerry Wentworth Ownership Network
Ownership Network List of Kerry Wentworth
Ownership Network Relation of Kerry Wentworth
Kerry Wentworth Owned Company Details
What does Flexion Therapeutics Inc do?
Who are the key executives at Flexion Therapeutics Inc?
Kerry Wentworth is the Chief Regulatory Officer of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Strategy Officer Christina Willwerth , General Counsel Mark S. Levine , and Chief Financial Officer David Arkowitz .
Flexion Therapeutics Inc (FLXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Flexion Therapeutics Inc Insider Transactions
Kerry Wentworth Mailing Address
Above is the net worth, insider trading, and ownership report for Kerry Wentworth. You might contact Kerry Wentworth via mailing address: Agenus Inc., 3 Forbes Road, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
